Moderna Narrows Loss, Says New Norovirus Vaccine Didn't Meet Expectations
Moderna(US:MRNA) WSJ·2026-07-31 19:45核心财务表现 - Moderna在最近一个季度亏损收窄 [1] - 公司营收出现增长 [1] 营收驱动因素 - 营收增长受到英国政府合同项下交付的推动 [1]
Moderna(US:MRNA) WSJ·2026-07-31 19:45Moderna(US:MRNA) WSJ·2026-07-31 19:45